Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Contraceptive Technology Update

RSS  

Articles

  • CDC Updates Guidance On Zika Prevention

    The CDC has updated its guidance on prevention of the Zika virus, calling for women and men who are planning to become pregnant in the near future to consider avoiding nonessential travel to areas with active Zika virus transmission.
  • Clinical Challenge: Easing IUD Insertion Pain?

    IUD) insertion is painful for many women, particularly nulliparous women; studies have not demonstrated an effective strategy to lessen this discomfort.
  • Updating the Guidance On Women’s Preventive Services

    A coalition of national health professional organizations, as well as women’s health consumer and patient advocates, are updating the federal Women’s Preventive Services Guidelines. If the recommendations are adopted by the Department of Health and Human Services’ Health Resources and Services Administration, it will help ensure that women receive a comprehensive set of preventive services without having to pay a copayment, co-insurance, or deductible.

  • Federal Agencies Issue More Family Planning Rules

    Federal agencies are continuing to issue regulations and guidance with a sense of urgency, and, in several cases, the implications for family planning care may be profound.

  • Research Eyes Hormonal Contraceptive Use And Impact on Vitamin D Levels

    Women risk having their vitamin D levels fall when they stop using birth control pills or other contraceptives containing estrogen, new research indicates. This finding has clinical implications when counseling women who are planning to conceive and identifying women who may be at risk of deficiency.

  • WHO Updates STI Treatment Guidance Due to Growing Antibiotic Resistance

    The World Health Organization has issued new guidelines for the treatment of chlamydia, gonorrhea, and syphilis in response to the growing threat of antibiotic resistance. According to the international health organization, each year, 131 million people are infected with chlamydia, 78 million are infected with gonorrhea, and 5.6 million are infected with syphilis.

  • Deaths From Ovarian Cancer Fall Worldwide Due to Oral Contraceptive Use, Data Show

    Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline through 2020 in the United States, European Union, and, to a lesser extent, in Japan, according to newly published research. The primary reason is the use of oral contraceptives and the long-term protection against ovarian cancer that they provide, say researchers.

  • LARC Options Expand With New Intrauterine Device

    Family planning clinicians are adding another choice to the expanding list of long-acting reversible contraceptive options with the September 2016 FDA approval of the Kyleena 19.5 mg levonorgestrel IUD from Whippany, NJ-based Bayer HealthCare Pharmaceuticals. The new IUD is available as of October 2016 by prescription only.

  • U.S. Preventive Services Task Force Recommends Against Genital Herpes Screening

    The CDC estimates that about one in six U.S. residents ages 14-49 has genital herpes.1 In new draft guidance, the U.S. Preventive Services Task Force (USPSTF) recommends against using current blood tests to screen for genital herpes in people with no signs or symptoms of infection, including adolescents and adults, as well as pregnant women.2

  • The Trajectories of Vasomotor Symptoms Eyed Across the Menopausal Transition

    Most women will get hot flashes or night sweats at some point during menopause. Research indicates 42% to 79% of women experience vasomotor symptoms (VMSs) during the menopausal transition.1-4 Just-published findings show that women fit into four distinct groups when it comes to having hot flashes and night sweats, which offers potential ramifications for therapy and prevention of future health conditions, according to research led by the Graduate School of Public Health at the University of Pittsburgh.5